Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.000
+0.010 (1.01%)
Jun 20, 2025, 4:00 PM - Market closed
Dyadic International Revenue
Dyadic International had revenue of $393.57K in the quarter ending March 31, 2025, with 17.62% growth. This brings the company's revenue in the last twelve months to $3.55M, up 57.59% year-over-year. In the year 2024, Dyadic International had annual revenue of $3.50M with 20.58% growth.
Revenue (ttm)
$3.55M
Revenue Growth
+57.59%
P/S Ratio
7.59
Revenue / Employee
$592,391
Employees
6
Market Cap
30.09M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.50M | 596.58K | 20.58% |
Dec 31, 2023 | 2.90M | -31.50K | -1.07% |
Dec 31, 2022 | 2.93M | 526.47K | 21.90% |
Dec 31, 2021 | 2.40M | 801.91K | 50.06% |
Dec 31, 2020 | 1.60M | -79.16K | -4.71% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
DYAI News
- 20 days ago - Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications - GlobeNewsWire
- 5 weeks ago - Dyadic International, Inc. (DYAI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - GlobeNewsWire
- 2 months ago - Dyadic to Present at World Vaccine Congress | Washington - GlobeNewsWire
- 3 months ago - Dyadic International, Inc. (DYAI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Dyadic Reports 2024 Year-End Financial Results and Business Updates - GlobeNewsWire
- 3 months ago - Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025 - GlobeNewsWire
- 3 months ago - Dyadic to Attend Multiple Industry Events in March - GlobeNewsWire